Financhill
Sell
43

DOW Quote, Financials, Valuation and Earnings

Last price:
$30.51
Seasonality move :
-4.59%
Day range:
$29.49 - $31.07
52-week range:
$20.40 - $40.09
Dividend yield:
6.88%
P/E ratio:
62.68x
P/S ratio:
0.54x
P/B ratio:
1.37x
Volume:
17.9M
Avg. volume:
13.6M
1-year change:
-22.91%
Market cap:
$21.9B
Revenue:
$40B
EPS (TTM):
-$3.69
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $55B $56.9B $44.6B $43B $40B
Revenue Growth (YoY) 42.62% 3.52% -21.58% -3.72% -6.97%
 
Cost of Revenues $44.6B $49B $39.7B $38.5B $37.5B
Gross Profit $10.4B $7.9B $5B $4.5B $2.5B
Gross Profit Margin 18.9% 13.81% 11.14% 10.37% 6.15%
 
R&D Expenses $857M $851M $829M $810M $752M
Selling, General & Admin $1.6B $1.7B $1.6B $1.6B $1.4B
Other Inc / (Exp) $934M $877M -$927M $306M --
Operating Expenses $2.5B $2.5B $2.5B $2.4B $2.1B
Operating Income $7.9B $5.3B $2.5B $2.1B $313M
 
Net Interest Expenses $689M $651M $736M $758M $880M
EBT. Incl. Unusual Items $8.1B $6.1B $656M $1.6B -$2.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.7B $1.5B -$4M $399M -$67M
Net Income to Company $6.4B $4.6B $660M $1.2B -$2.4B
 
Minority Interest in Earnings $94M $58M $71M $85M $179M
Net Income to Common Excl Extra Items $6.4B $4.6B $649M $1.2B -$2.5B
 
Basic EPS (Cont. Ops) $8.44 $6.32 $0.82 $1.57 -$3.70
Diluted EPS (Cont. Ops) $8.38 $6.28 $0.82 $1.57 -$3.70
Weighted Average Basic Share $743.6M $721M $705.7M $703.8M $711.6M
Weighted Average Diluted Share $749M $725.6M $709M $705.1M $711.6M
 
EBITDA $10.7B $8.1B $5.1B $5B $3.1B
EBIT $7.9B $5.3B $2.5B $2.1B $313M
 
Revenue (Reported) $55B $56.9B $44.6B $43B $40B
Operating Income (Reported) $7.9B $5.3B $2.5B $2.1B $313M
Operating Income (Adjusted) $7.9B $5.3B $2.5B $2.1B $313M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $14.4B $11.9B $10.6B $10.4B $9.5B
Revenue Growth (YoY) 34.17% -17.44% -10.44% -2.03% -9.08%
 
Cost of Revenues $11.9B $10.8B $9.6B $9.5B $8.9B
Gross Profit $2.5B $1B $976M $877M $515M
Gross Profit Margin 17.18% 8.61% 9.19% 8.43% 5.44%
 
R&D Expenses $225M $225M $213M $202M $173M
Selling, General & Admin $436M $386M $411M $353M $339M
Other Inc / (Exp) $430M $460M -$468M $74M --
Operating Expenses $661M $611M $624M $555M $512M
Operating Income $1.8B $410M $352M $322M $3M
 
Net Interest Expenses $165M $173M $197M $173M $210M
EBT. Incl. Unusual Items $2.1B $865M -$352M $219M -$1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $357M $218M -$257M $254M -$71M
Net Income to Company $1.8B $647M -$95M -$35M -$1.5B
 
Minority Interest in Earnings $25M $34M $10M $18M $66M
Net Income to Common Excl Extra Items $1.8B $644M -$98M -$38M -$1.5B
 
Basic EPS (Cont. Ops) $2.34 $0.86 -$0.15 -$0.08 -$2.15
Diluted EPS (Cont. Ops) $2.32 $0.86 -$0.15 -$0.08 -$2.15
Weighted Average Basic Share $738.1M $709.2M $703.6M $704.7M $718.2M
Weighted Average Diluted Share $743.3M $713M $703.6M $704.7M $718.2M
 
EBITDA $2.5B $1.1B $1B $1.1B $711M
EBIT $1.8B $410M $352M $322M $3M
 
Revenue (Reported) $14.4B $11.9B $10.6B $10.4B $9.5B
Operating Income (Reported) $1.8B $410M $352M $322M $3M
Operating Income (Adjusted) $1.8B $410M $352M $322M $3M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $55B $56.9B $44.6B $43B $40B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $44.6B $48.9B $39.8B $38.5B $37.5B
Gross Profit $10.4B $8B $4.9B $4.4B $2.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $857M $851M $829M $810M $752M
Selling, General & Admin $1.6B $1.7B $1.6B $1.6B $1.4B
Other Inc / (Exp) $934M $877M -$927M $306M --
Operating Expenses $2.5B $2.5B $2.5B $2.4B $2.1B
Operating Income $7.9B $5.4B $2.4B $2.1B $324M
 
Net Interest Expenses $689M $651M $740M $758M $880M
EBT. Incl. Unusual Items $8.1B $6.1B $656M $1.6B -$2.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.7B $1.5B -$4M $399M -$67M
Net Income to Company $6.4B $4.6B $660M $1.2B -$2.4B
 
Minority Interest in Earnings $94M $58M $71M $85M $179M
Net Income to Common Excl Extra Items $6.4B $4.6B $649M $1.2B -$2.5B
 
Basic EPS (Cont. Ops) $8.44 $6.29 $0.82 $1.57 -$3.69
Diluted EPS (Cont. Ops) $8.38 $6.25 $0.81 $1.57 -$3.69
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $10.7B $8.2B $5B $4.9B $3.2B
EBIT $7.9B $5.4B $2.4B $2.1B $324M
 
Revenue (Reported) $55B $56.9B $44.6B $43B $40B
Operating Income (Reported) $7.9B $5.4B $2.4B $2.1B $324M
Operating Income (Adjusted) $7.9B $5.4B $2.4B $2.1B $324M
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Revenue $56.9B $44.6B $43B $40B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $48.9B $39.8B $38.5B $37.5B --
Gross Profit $8B $4.9B $4.4B $2.5B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $851M $829M $810M $752M --
Selling, General & Admin $1.7B $1.6B $1.6B $1.4B --
Other Inc / (Exp) $877M -$927M $306M -$689M --
Operating Expenses $2.5B $2.5B $2.4B $2.1B --
Operating Income $5.4B $2.4B $2.1B $324M --
 
Net Interest Expenses $651M $740M $758M $880M --
EBT. Incl. Unusual Items $6.1B $656M $1.6B -$2.5B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.5B -$4M $399M -$67M --
Net Income to Company $4.6B $660M $1.2B -$2.4B --
 
Minority Interest in Earnings $58M $71M $85M $179M --
Net Income to Common Excl Extra Items $4.6B $649M $1.2B -$2.5B --
 
Basic EPS (Cont. Ops) $6.29 $0.82 $1.57 -$3.69 --
Diluted EPS (Cont. Ops) $6.25 $0.81 $1.57 -$3.69 --
Weighted Average Basic Share $2.9B $2.8B $2.8B $2.8B --
Weighted Average Diluted Share $2.9B $2.8B $2.8B $2.8B --
 
EBITDA $8.2B $5B $4.9B $3.2B --
EBIT $5.4B $2.4B $2.1B $324M --
 
Revenue (Reported) $56.9B $44.6B $43B $40B --
Operating Income (Reported) $5.4B $2.4B $2.1B $324M --
Operating Income (Adjusted) $5.4B $2.4B $2.1B $324M --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $3.3B $4.9B $4.3B $2.6B $4.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $6.9B $5.7B $4.7B $4.8B $4.8B
Inventory $7.4B $7B $6.1B $6.5B $6.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $934M $1.8B $1.9B $993M --
Total Current Assets $20.8B $20.5B $17.6B $16.6B $18.1B
 
Property Plant And Equipment $22B $21.7B $22.4B $23.3B $23.6B
Long-Term Investments $5.7B $5.1B $4.5B $4.7B $4.6B
Goodwill $8.8B $8.6B $8.6B $8.6B --
Other Intangibles $2.9B $2.4B $2.1B $1.7B --
Other Long-Term Assets $1.5B $1.4B $1.3B $1.2B --
Total Assets $63B $60.6B $58B $57.3B $58.5B
 
Accounts Payable $5.6B $4.9B $4.5B $4.8B $4.2B
Accrued Expenses $3.5B $2.8B $2.7B $2.5B --
Current Portion Of Long-Term Debt $231M $362M $117M $497M --
Current Portion Of Capital Lease Obligations $314M $287M $329M $318M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $13.2B $11.3B $10B $10.3B $9.2B
 
Long-Term Debt $15.4B $15.7B $15.9B $16.7B $18.9B
Capital Leases -- -- -- -- --
Total Liabilities $44.3B $39.4B $38.9B $39.5B $41B
 
Common Stock $8M $8M $8M $8M $8M
Other Common Equity Adj -$9B -$7.1B -$7.7B -$8.1B --
Common Equity $18.2B $20.7B $18.6B $17.4B $16B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $574M $529M $501M $496M $1.5B
Total Equity $18.7B $21.2B $19.1B $17.9B $17.5B
 
Total Liabilities and Equity $63B $60.6B $58B $57.3B $58.5B
Cash and Short Terms $3.3B $4.9B $4.3B $2.6B $4.3B
Total Debt $15.7B $16.1B $16.1B $17.2B $19.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $3.3B $4.9B $4.3B $2.6B $4.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $6.9B $5.7B $4.7B $4.8B $4.8B
Inventory $7.4B $7B $6.1B $6.5B $6.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $934M $1.8B $1.9B $993M --
Total Current Assets $20.8B $20.5B $17.6B $16.6B $18.1B
 
Property Plant And Equipment $22B $21.7B $22.4B $23.3B $23.6B
Long-Term Investments $5.7B $5.1B $4.5B $4.7B $4.6B
Goodwill $8.8B $8.6B $8.6B $8.6B --
Other Intangibles $2.9B $2.4B $2.1B $1.7B --
Other Long-Term Assets $1.5B $1.4B $1.3B $1.2B --
Total Assets $63B $60.6B $58B $57.3B $58.5B
 
Accounts Payable $5.6B $4.9B $4.5B $4.8B $4.2B
Accrued Expenses $3.5B $2.8B $2.7B $2.5B --
Current Portion Of Long-Term Debt $231M $362M $117M $497M --
Current Portion Of Capital Lease Obligations $314M $287M $329M $318M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $13.2B $11.3B $10B $10.3B $9.2B
 
Long-Term Debt $15.4B $15.7B $15.9B $16.7B $18.9B
Capital Leases -- -- -- -- --
Total Liabilities $44.3B $39.4B $38.9B $39.5B $41B
 
Common Stock $8M $8M $8M $8M $8M
Other Common Equity Adj -$9B -$7.1B -$7.7B -$8.1B --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $574M $529M $501M $496M $1.5B
Total Equity $18.7B $21.2B $19.1B $17.9B $17.5B
 
Total Liabilities and Equity $63B $60.6B $58B $57.3B $58.5B
Cash and Short Terms $3.3B $4.9B $4.3B $2.6B $4.3B
Total Debt $15.7B $16.1B $16.1B $17.2B $19.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $6.4B $4.6B $660M $1.2B -$2.4B
Depreciation & Amoritzation $2.8B $2.8B $2.6B $2.9B $2.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.1B $1.2B $1.2B -$224M $73M
Change in Inventories -$1.8B $347M $844M -$529M -$52M
Cash From Operations $7B $7.5B $5.2B $2.9B $1B
 
Capital Expenditures $2.2B $1.8B $2.4B $2.9B $2.5B
Cash Acquisitions $129M $228M $114M $125M --
Cash From Investing -$2.9B -$3B -$2.9B -$2.4B $817M
 
Dividends Paid (Ex Special Dividend) $2.1B $2B $2B $2B $1.5B
Special Dividend Paid
Long-Term Debt Issued $253M $1.9B $104M $1.6B --
Long-Term Debt Repaid -$2.9B -$1B -$695M -$345M --
Repurchase of Common Stock $1B $2.3B $625M $494M --
Other Financing Activities -$622M -$142M -$115M -$139M --
Cash From Financing -$6.1B -$3.4B -$3.1B -$1.2B -$435M
 
Beginning Cash (CF) $3B $3.9B $3B $2.3B $4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.1B $907M -$892M -$785M $1.7B
Ending Cash (CF) $859M $4.6B $2.1B $1.3B $5.9B
 
Levered Free Cash Flow $4.8B $5.6B $2.8B -$26M -$1.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1.8B $647M -$95M -$35M -$1.5B
Depreciation & Amoritzation $655M $654M $657M $751M $708M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $90M $864M $796M $594M $473M
Change in Inventories -$266M $601M $67M $147M $80M
Cash From Operations $2.6B $2.1B $1.7B $814M $284M
 
Capital Expenditures $1.2B $601M $760M $767M $568M
Cash Acquisitions $22M $174M $11M $4M --
Cash From Investing -$1.4B -$1.6B -$1.1B -$912M -$669M
 
Dividends Paid (Ex Special Dividend) $512M $495M $491M $492M $251M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $14M $1.8B $28M $53M --
Long-Term Debt Repaid -$267M -$49M -$218M -$54M --
Repurchase of Common Stock $400M $125M $125M -- --
Other Financing Activities -$40M -$58M -$30M -$67M --
Cash From Financing -$1.1B $1.2B -$711M -$445M -$433M
 
Beginning Cash (CF) $3B $3.9B $3B $2.3B $4B
Foreign Exchange Rate Adjustment -$42M $24M $85M -$181M $16M
Additions / Reductions $57M $1.6B -$52M -$724M -$802M
Ending Cash (CF) $3B $5.6B $3.1B $1.4B $3.2B
 
Levered Free Cash Flow $1.4B $1.5B $896M $47M -$284M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $6.4B $4.6B $660M $1.2B -$2.4B
Depreciation & Amoritzation $2.8B $2.8B $2.6B $2.9B $2.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.1B $1.2B $1.2B -$224M $73M
Change in Inventories -$1.8B $347M $844M -$529M -$52M
Cash From Operations $7B $7.5B $5.2B $2.9B $1B
 
Capital Expenditures $2.2B $1.8B $2.4B $2.9B $2.5B
Cash Acquisitions -- $228M $114M $125M --
Cash From Investing -$2.9B -$3B -$2.9B -$2.4B $817M
 
Dividends Paid (Ex Special Dividend) $2.1B $2B $2B $2B $1.5B
Special Dividend Paid
Long-Term Debt Issued $253M $1.9B $104M $1.6B --
Long-Term Debt Repaid -$2.9B -$1B -$695M -$345M --
Repurchase of Common Stock $1B $2.3B $625M $494M --
Other Financing Activities -$622M -$142M -$115M -$139M --
Cash From Financing -$6.1B -$3.4B -$3.1B -$1.2B -$435M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.1B $907M -$892M -$785M $1.7B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $4.8B $5.6B $2.8B -$26M -$1.4B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $4.6B $660M $1.2B -$2.4B --
Depreciation & Amoritzation $2.8B $2.6B $2.9B $2.8B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $1.2B $1.2B -$224M $73M --
Change in Inventories $347M $844M -$529M -$52M --
Cash From Operations $7.5B $5.2B $2.9B $1B --
 
Capital Expenditures $1.8B $2.4B $2.9B $2.5B --
Cash Acquisitions $228M $114M $125M -- --
Cash From Investing -$3B -$2.9B -$2.4B $817M --
 
Dividends Paid (Ex Special Dividend) $2B $2B $2B $1.5B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.9B $104M $1.6B $1.2B --
Long-Term Debt Repaid -$1B -$695M -$345M -$1.2B --
Repurchase of Common Stock $2.3B $625M $494M -- --
Other Financing Activities -$142M -$115M -$139M $2.3B --
Cash From Financing -$3.4B -$3.1B -$1.2B -$435M --
 
Beginning Cash (CF) $11.9B $12.6B $12.4B $12.8B --
Foreign Exchange Rate Adjustment -$237M -$45M -$163M $275M --
Additions / Reductions $907M -$892M -$785M $1.7B --
Ending Cash (CF) $12.6B $11.6B $11.4B $14.7B --
 
Levered Free Cash Flow $5.6B $2.8B -$26M -$1.4B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock